ROC was tested for validation in prediction of the occurrence of MG and the results showed that Tfh cells and genes such as HMGA1, TP53 and TFAP2A could effectively predict MG occurrence in thymoma patients (Figure 9 and Table 1). The gene discussed is TFAP2A; the disease is myasthenia gravis.